Pershing Square Capital Management
Bill Ackman Files for Largest-Ever SPAC Offering
The investor is betting that blank-check mergers continue to be an attractive alternative to traditional IPOs amid the current market volatility.
Activist Investor Can’t Dodge Insider Trading Suit
A judge finds Bill Ackman can be sued for allegedly buying a stake in Allergan based on inside information about a takeover bid by Valeant Pharmaceuticals.
Ackman’s Allergan Takeover Bid Is Easier Said Than Done
The takeover contest's outcome becomes unclear when we consider the conflict between the hedge fund’s objectives and the Allergan board's fiduciary duty.